Publication | Open Access
Effects of Topical and Subconjunctival Bevacizumab in High-Risk Corneal Transplant Survival
91
Citations
39
References
2010
Year
Subconjunctival bevacizumab may offer an adjunctive measure to conventional therapies in preventing graft rejection in high-risk corneal transplantation.
| Year | Citations | |
|---|---|---|
Page 1
Page 1